Last update: March 24, 2015

Midecamycin

Low Risk for breastfeeding


Moderately safe. Probably compatible.
Mild risk possible. Follow up recommended.
Read the Comment.

It is a Macrolide-type antibiotic.

At latest update, relevant published data on excretion into breast milk were not found.

A high molecular weight makes excretion into breast milk be very unlikely.

Until more data on this medication is available, safer alternative drugs are preferred, especially in such critical age periods.

Be aware of false negative results of bacterial cultures from febrile infants, that may occur when breastfeeding mothers are taking antibiotics.

Alternatives

Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Group

Midecamycin belongs to this group or family:

Tradenames

Main tradenames from several countries containing Midecamycin in its composition:

Pharmacokinetics

Variable Value Unit
Molecular weight 814 daltons
Protein Binding 47 %
Tmax 0,5 - 1 hours
T1/2 1 - 3 hours

References

  1. Midecamicina. Ficha técnica. 1999 Full text (in our servers)
  2. Periti P, Mazzei T, Mini E, Novelli A. Clinical pharmacokinetic properties of the macrolide antibiotics. Effects of age and various pathophysiological states (Part I). Clin Pharmacokinet. 1989 Abstract

Total visits

3,249

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write to us at elactancia.org@gmail.com

e-lactancia is a resource recommended by Academy of Breastfeeding Medicine from United States of America

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM